Wealth Enhancement Advisory Services, LLC Moderna, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 13,431 shares of MRNA stock, worth $447,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,431
Previous 8,313
61.57%
Holding current value
$447,520
Previous $345,000
61.74%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MRNA
# of Institutions
927Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.34 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.3 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$852 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$586 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$243 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...